Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to oral therapy ...

General and administrative expense for the year ended December 31, 2024 increased to $4.7 million, compared to $4.2 million for the year ended December 31, 2023 primarily due to increased salaries and ...

Scientists at Johns Hopkins Medicine have discovered that an experimental drug originally developed for other health problems ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related diseases in a uniquely comprehensive and reliable manner.

Obesity remains a global health crisis, often linked to serious diseases such as diabetes, heart disease, and fatty liver ...

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related ...

Obesity was tied with an increased risk of developing 16 health outcomes, a large longitudinal study showed. Risks correlated ...

A new University of Michigan study shows that a strong majority of older Americans want health insurance — including Medicare — to cover weight loss medica ...

Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...